Complete Filing Data
Entera Bio Ltd. reported Stockholders Equity of $13.10 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Entera Bio Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$11.4M | -$9.5M | -$8.9M | -$13.1M | -$12.2M | -$11.2M | -$10.8M | -$10.3M | -$11.2M | -$1.2M |
| Research And Development Expense | $6.0M | $4.5M | $4.5M | $5.8M | $6.8M | $6.4M | $7.2M | $8.5M | $2.8M | $2.6M |
| General And Administrative Expense | $5.5M | $5.1M | $4.4M | $7.3M | $5.7M | $4.9M | $4.3M | $2.8M | $8.6M | $2.7M |
| Operating Income Loss | -$11.5M | -$9.6M | -$8.9M | -$13.0M | -$12.2M | -$11.2M | ||||
| Operating Expenses | $11.5M | $9.6M | $8.9M | $13.1M | $12.4M | $11.2M | ||||
| Nonoperating Income Expense | $90.0K | $58.0K | $31.0K | $83.0K | -$29.0K | -$28.0K | ||||
| Revenues | $42.0K | $181.0K | $0.00 | $134.0K | $571.0K | $365.0K | ||||
| Cost Of Revenue | $42.0K | $172.0K | $0.00 | $101.0K | $373.0K | $300.0K | ||||
| Gross Profit | $0.00 | $9.0K | $0.00 | $33.0K | $198.0K | $65.0K | ||||
| Income Tax Expense Benefit | $0.00 | $14.0K | $29.0K | $137.0K | -$59.0K | $20.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$11.4M | -$9.5M | -$8.9M | -$12.9M | -$12.2M | -$11.2M | ||||
| Deferred Income Tax Assets Net | $0.00 | $14.0K | $43.0K | $217.0K | $0.00 | |||||
| Deferred Income Tax Expense Benefit | $0.00 | $14.0K | $29.0K | $174.0K | -$217.0K | $0.00 | ||||
| Profit Loss From Operating Activities | -$11.1M | -$11.5M | -$10.9M | -$11.3M | -$5.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.2M | -$2.7M | -$2.6M | -$3.0M | -$2.1M | -$2.0M | -$2.4M | -$2.3M | -$2.2M | -$3.1M | -$3.2M | -$3.8M | -$3.2M | -$2.6M | -$2.3M |
| Research And Development Expense | $1.6M | $1.5M | $1.1M | $1.5M | $1.1M | $735.0K | $1.4M | $1.2M | $931.0K | $1.4M | $1.4M | $1.7M | $1.8M | $1.2M | $1.1M |
| General And Administrative Expense | $1.6M | $1.1M | $1.4M | $1.5M | $1.1M | $1.3M | $1.0M | $1.1M | $1.3M | $1.5M | $1.9M | $2.2M | $1.5M | $1.4M | $1.3M |
| Operating Income Loss | -$3.3M | -$2.7M | -$2.6M | -$3.0M | -$2.2M | -$2.1M | -$2.4M | -$2.3M | -$2.2M | -$2.9M | -$3.2M | -$3.8M | -$3.2M | -$2.6M | -$2.3M |
| Operating Expenses | $3.3M | $2.7M | $2.6M | $3.0M | $2.2M | $2.1M | $2.4M | $2.3M | $2.2M | $2.9M | $3.3M | $3.8M | $3.3M | $2.6M | $2.4M |
| Nonoperating Income Expense | $56.0K | $12.0K | -$4.0K | $0.00 | $20.0K | $45.0K | $36.0K | $5.0K | $22.0K | -$8.0K | $60.0K | $44.0K | -$7.0K | -$24.0K | $29.0K |
| Revenues | $0.00 | $0.00 | $42.0K | $42.0K | $57.0K | $0.00 | $0.00 | $0.00 | $0.00 | $8.0K | $44.0K | $68.0K | $140.0K | $109.0K | $157.0K |
| Cost Of Revenue | $0.00 | $0.00 | $42.0K | $42.0K | $48.0K | $0.00 | $0.00 | $0.00 | $0.00 | $6.0K | $33.0K | $54.0K | $65.0K | $99.0K | $73.0K |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | $9.0K | $0.00 | $0.00 | $0.00 | $2.0K | $11.0K | $14.0K | $75.0K | $10.0K | $84.0K | |
| Income Tax Expense Benefit | $0.00 | $29.0K | $0.00 | $0.00 | $194.0K | -$4.0K | -$7.0K | -$13.0K | -$17.0K | -$14.0K | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.0M | -$2.4M | -$2.3M | -$2.2M | -$2.9M | -$3.2M | -$3.8M | -$3.2M | -$2.6M | -$2.3M | |||||
| Deferred Income Tax Assets Net | $14.0K | $14.0K | $14.0K | $15.0K | $43.0K | $43.0K | $66.0K | $280.0K | $250.0K | ||||||
| Deferred Income Tax Expense Benefit | $0.00 | -$33.0K | -$52.0K | ||||||||||||
| Profit Loss From Operating Activities |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $13.1M | $8.1M | $10.4M | $11.8M | $22.6M | $7.5M | $13.8M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.0M | $8.7M | $11.1M | $12.4M | $25.0M | $8.7M | $15.2M | ||||
| Cash And Cash Equivalents At Carrying Value | $7.1M | $8.7M | $11.0M | $12.3M | $24.9M | $8.6M | |||||
| Liabilities | $2.9M | $1.3M | $1.4M | $1.4M | $3.4M | $2.2M | $4.8M | $3.2M | $44.8M | ||
| Assets | $16.0M | $9.4M | $11.8M | $13.1M | $26.0M | $9.7M | $16.7M | $13.3M | $13.3M | ||
| Retained Earnings Accumulated Deficit | -$125.4M | -$113.9M | -$104.4M | -$95.5M | -$82.4M | -$70.2M | |||||
| Restricted Cash And Cash Equivalents | $7.8M | $0.00 | $66.0K | $67.0K | $72.0K | $70.0K | |||||
| Property Plant And Equipment Net | $134.0K | $57.0K | $100.0K | $139.0K | $156.0K | $192.0K | |||||
| Postemployment Benefits Liability Noncurrent | $36.0K | $32.0K | $32.0K | $32.0K | $138.0K | $128.0K | |||||
| Operating Lease Right Of Use Asset | $465.0K | $275.0K | $388.0K | $90.0K | $239.0K | $374.0K | |||||
| Operating Lease Liability Current | $230.0K | $170.0K | $134.0K | $91.0K | $179.0K | $189.0K | |||||
| Liabilities Noncurrent | $689.0K | $134.0K | $288.0K | $32.0K | $261.0K | $371.0K | |||||
| Liabilities Current | $2.2M | $1.2M | $1.1M | $1.3M | $3.2M | $1.8M | |||||
| Liabilities And Stockholders Equity | $16.0M | $9.4M | $11.8M | $13.1M | $26.0M | $9.7M | |||||
| Defined Benefit Plan Assets For Plan Benefits Noncurrent | $6.0K | $6.0K | $6.0K | $6.0K | $46.0K | $47.0K | |||||
| Assets Noncurrent | $695.0K | $418.0K | $508.0K | $278.0K | $658.0K | $613.0K | |||||
| Assets Current | $15.3M | $9.0M | $11.3M | $12.8M | $25.3M | $9.1M | |||||
| Additional Paid In Capital Common Stock | $138.4M | $122.0M | $114.7M | $107.2M | $105.0M | $77.7M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |||||
| Accrued Liabilities And Other Liabilities | $1.5M | $874.0K | $874.0K | $1.2M | $2.8M | $1.3M | |||||
| Accounts Payable Current | $448.0K | $132.0K | $83.0K | $17.0K | $166.0K | $164.0K | |||||
| Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities | $386.0K | $32.0K | $449.0K | $0.00 | $31.0K | $258.0K | |||||
| Operating Lease Liability Noncurrent | $260.0K | $102.0K | $256.0K | $0.00 | $123.0K | $243.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $6.2M | -$2.3M | -$1.3M | -$12.6M | $16.3M | -$6.6M | |||||
| Accounts Receivable Net Current | $0.00 | $126.0K | $0.00 | $246.0K | $183.0K | $255.0K | |||||
| Equity | $13.1M | $8.1M | $10.4M | $11.8M | $22.6M | $7.5M | $13.8M | ||||
| Cash And Cash Equivalents | $8.6M | $15.2M | $7.5M | $11.7M | $4.2M | $1.2M | |||||
| Other Assets Current | $415.0K | $186.0K | $238.0K | $294.0K | $254.0K | $261.0K | |||||
| Income From Change In Fair Value Of Financial Liabilities At Fair Value Through Profit And Loss | $1.2M | $743.0K | $523.0K | $251.0K | $4.3M | ||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $15.2M | $17.3M | $19.4M | $6.5M | $8.5M | $8.9M | $6.2M | $8.2M | $10.1M | $14.3M | $17.3M | $19.7M | $26.3M | $26.3M | $15.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.7M | $19.0M | $20.7M | $7.0M | $9.1M | $9.3M | $7.7M | $9.2M | $10.8M | $14.4M | $17.3M | $20.1M | $27.5M | $27.0M | $16.5M |
| Cash And Cash Equivalents At Carrying Value | $8.6M | $10.9M | $12.6M | $6.9M | $9.1M | $9.2M | $7.6M | $9.1M | $10.7M | $14.3M | $17.3M | $20.1M | $27.4M | $26.9M | $16.4M |
| Liabilities | $2.2M | $2.4M | $2.2M | $1.3M | $1.5M | $1.4M | $2.3M | $2.2M | $1.5M | $1.2M | $1.8M | $2.6M | |||
| Assets | $17.4M | $19.7M | $21.6M | $7.7M | $10.0M | $10.2M | $8.6M | $10.4M | $11.6M | $15.5M | $19.1M | $22.3M | |||
| Retained Earnings Accumulated Deficit | -$122.4M | -$119.2M | -$116.5M | -$111.6M | -$108.5M | -$106.4M | -$102.4M | -$100.0M | -$97.7M | -$92.5M | -$89.4M | -$86.2M | |||
| Restricted Cash And Cash Equivalents | $8.1M | $8.1M | $8.1M | $78.0K | $78.0K | $64.0K | $91.0K | $66.0K | $65.0K | $67.0K | $37.0K | $40.0K | $70.0K | $70.0K | $70.0K |
| Property Plant And Equipment Net | $114.0K | $79.0K | $57.0K | $65.0K | $76.0K | $87.0K | $108.0K | $122.0K | $136.0K | $152.0K | $166.0K | $163.0K | |||
| Postemployment Benefits Liability Noncurrent | $34.0K | $34.0K | $32.0K | $31.0K | $30.0K | $31.0K | $31.0K | $32.0K | $32.0K | $32.0K | $122.0K | $135.0K | |||
| Operating Lease Right Of Use Asset | $194.0K | $190.0K | $227.0K | $316.0K | $344.0K | $381.0K | $420.0K | $460.0K | $48.0K | $126.0K | $170.0K | $212.0K | |||
| Operating Lease Liability Current | $170.0K | $194.0K | $169.0K | $162.0K | $155.0K | $153.0K | $131.0K | $140.0K | $48.0K | $129.0K | $172.0K | $142.0K | |||
| Liabilities Noncurrent | $602.0K | $567.0K | $598.0K | $178.0K | $209.0K | $255.0K | $302.0K | $348.0K | $32.0K | $35.0K | $127.0K | $233.0K | |||
| Liabilities Current | $1.6M | $1.8M | $1.6M | $1.1M | $1.3M | $1.1M | $2.0M | $1.9M | $1.5M | $1.2M | $1.7M | $2.3M | |||
| Liabilities And Stockholders Equity | $17.4M | $19.7M | $21.6M | $7.7M | $10.0M | $10.2M | $8.6M | $10.4M | $11.6M | $15.5M | $19.1M | $22.3M | |||
| Defined Benefit Plan Assets For Plan Benefits Noncurrent | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $46.0K | $46.0K | |||
| Assets Noncurrent | $400.0K | $356.0K | $382.0K | $401.0K | $440.0K | $488.0K | $549.0K | $631.0K | $233.0K | $350.0K | $662.0K | $671.0K | |||
| Assets Current | $17.0M | $19.3M | $21.2M | $7.3M | $9.6M | $9.8M | $8.0M | $9.8M | $11.4M | $15.2M | $18.4M | $21.6M | |||
| Additional Paid In Capital Common Stock | $137.5M | $136.4M | $135.8M | $118.0M | $117.0M | $115.2M | $108.6M | $108.2M | $107.7M | $106.7M | $106.6M | $105.9M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |||
| Accrued Liabilities And Other Liabilities | $1.2M | $1.3M | $1.3M | $765.0K | $1.1M | $902.0K | $1.3M | $1.5M | $1.3M | $651.0K | $1.4M | $2.0M | |||
| Accounts Payable Current | $216.0K | $383.0K | $134.0K | $184.0K | $69.0K | $66.0K | $564.0K | $240.0K | $150.0K | $413.0K | $109.0K | $199.0K | |||
| Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities | $0.00 | $33.0K | $0.00 | $0.00 | $31.0K | ||||||||||
| Operating Lease Liability Noncurrent | $41.0K | $9.0K | $51.0K | $147.0K | $179.0K | $224.0K | $271.0K | $316.0K | $3.0K | $5.0K | $98.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $11.9M | -$1.8M | -$1.6M | -$4.8M | $7.8M | ||||||||||
| Accounts Receivable Net Current | $0.00 | $0.00 | $126.0K | $42.0K | $57.0K | $0.00 | $29.0K | $29.0K | $233.0K | $225.0K | $210.0K | ||||
| Equity | $15.2M | $17.3M | $19.4M | $6.5M | $8.5M | $8.9M | $6.2M | $8.2M | $10.1M | $14.3M | $17.3M | $19.7M | $26.3M | $26.3M | $15.7M |
| Cash And Cash Equivalents | |||||||||||||||
| Other Assets Current | $653.0K | $634.0K | $922.0K | $1.3M | |||||||||||
| Income From Change In Fair Value Of Financial Liabilities At Fair Value Through Profit And Loss | |||||||||||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $2.8M | $2.6M | $1.7M | $2.2M | $1.9M | $901.0K |
| Payments To Acquire Property Plant And Equipment | $107.0K | $3.0K | $17.0K | $47.0K | $17.0K | $53.0K |
| Net Cash Provided By Used In Operating Activities | -$7.4M | -$6.8M | -$7.3M | -$12.5M | -$9.1M | -$10.6M |
| Net Cash Provided By Used In Investing Activities | -$107.0K | -$3.0K | -$17.0K | -$102.0K | -$17.0K | -$53.0K |
| Increase Decrease In Other Current Assets | $229.0K | $14.0K | -$56.0K | $40.0K | -$7.0K | $55.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $1.0M | $203.0K | -$563.0K | -$1.6M | $1.5M | -$40.0K |
| Increase Decrease In Accounts Payable | $316.0K | $49.0K | $66.0K | -$149.0K | $2.0K | -$170.0K |
| Net Cash Provided By Used In Financing Activities | $13.7M | $4.5M | $6.0M | $13.0K | $25.4M | $4.1M |
| Increase Decrease In Accounts Receivable | -$126.0K | $126.0K | -$246.0K | $63.0K | -$72.0K | -$23.0K |
| Proceeds From Issuance Of Common Stock | $6.3M | $4.0M | $5.0K | $0.00 | $21.8M | $3.2M |
| Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$15.0K | -$143.0K | -$109.0K | ||
| Proceeds From Warrant Exercises | $508.0K | $90.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $604.0K | $464.0K | $516.0K | $964.0K | $327.0K | |||
| Payments To Acquire Property Plant And Equipment | $8.0K | $0.00 | $11.0K | $23.0K | $0.00 | |||
| Net Cash Provided By Used In Operating Activities | -$1.4M | -$1.9M | -$1.6M | -$4.8M | -$2.3M | |||
| Net Cash Provided By Used In Investing Activities | -$8.0K | $0.00 | -$11.0K | -$23.0K | $0.00 | |||
| Increase Decrease In Other Current Assets | $333.0K | $324.0K | $359.0K | $1.1M | $777.0K | |||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $886.0K | $28.0K | $63.0K | -$808.0K | $114.0K | |||
| Increase Decrease In Accounts Payable | $2.0K | -$17.0K | $133.0K | $33.0K | $276.0K | |||
| Net Cash Provided By Used In Financing Activities | $13.3M | $30.0K | $0.00 | $0.00 | $10.1M | |||
| Increase Decrease In Accounts Receivable | $0.00 | -$217.0K | $27.0K | -$240.0K | ||||
| Proceeds From Issuance Of Common Stock | $6.2M | $0.00 | $0.00 | $9.9M | ||||
| Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$15.0K | -$143.0K | |||||
| Proceeds From Warrant Exercises | $150.0K | $30.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.67 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 46.2M | 37.7M | 29.0M | 28.8M | 26.1M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 46.2M | 37.7M | 29.0M | 28.8M | 26.1M | |||||
| Earnings Per Share Basic | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | |||||
| Common Stock Shares Outstanding | 46.2M | 38.8M | 35.5M | 28.8M | 28.8M | 21.1M | ||||
| Common Stock Shares Issued | 46.2M | 38.8M | 35.5M | 28.8M | 28.8M | 21.1M | ||||
| Common Stock Shares Authorized | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Shares | 18.4M | 12.1M | 8.0M | 4.5M | 4.5M | |||||
| Diluted Earnings Loss Per Share | $0.55 | $0.89 | $1.31 | $2.49 | $0.78 | |||||
| Basic Earnings Loss Per Share | $0.54 | $0.89 | $1.30 | $2.49 | $0.27 | |||||
| Adjusted Weighted Average Shares | 18.6M | 12.1M | 8.0M | 4.5M | 6.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.07 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.08 | $0.08 | $0.08 | $0.11 | $0.11 | $0.13 | $0.11 | $0.10 | $0.10 |
| Weighted Average Number Of Shares Outstanding Basic | 47.1M | 46.8M | 43.4M | 37.6M | 37.1M | 36.7M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | 28.7M | 24.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 47.1M | 46.8M | 43.4M | 37.6M | 37.1M | 36.7M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | 28.7M | 24.7M | |
| Earnings Per Share Basic | $0.07 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.08 | $0.08 | $0.08 | $0.11 | $0.11 | $0.13 | $0.11 | $0.10 | |
| Common Stock Shares Outstanding | 45.7M | 45.5M | 45.4M | 36.5M | 36.3M | 35.5M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | |||
| Common Stock Shares Issued | 45.7M | 45.5M | 45.4M | 36.5M | 36.3M | 35.5M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | 28.8M | |||
| Common Stock Shares Authorized | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | 140.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Shares | |||||||||||||||
| Diluted Earnings Loss Per Share | |||||||||||||||
| Basic Earnings Loss Per Share | |||||||||||||||
| Adjusted Weighted Average Shares |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.8M | $2.6M | $1.7M | $2.2M | $1.9M | $901.0K | ||||
| Other Nonrecurring Income | $0.00 | $49.0K | $51.0K | $46.0K | $0.00 | |||||
| Depreciation | $30.0K | $46.0K | $56.0K | $64.0K | $53.0K | $63.0K | ||||
| Stock Issued During Period Value Issued For Services | $6.1M | $3.8M | $5.0K | $21.8M | $3.2M | |||||
| Finance Expenses Net | -$5.0K | $0.00 | -$78.0K | $18.0K | $46.0K | |||||
| Stock Issued During Period Value Stock Options Exercised | $7.1M | $749.0K | $13.0K | $418.0K | $68.0K | |||||
| Exercise Of Warrants Value | $508.0K | $90.0K | $3.2M | |||||||
| Interest Received | $180.0K | $68.0K | $18.0K | $0.00 | ||||||
| Financial Expenses Income Net | -$1.2M | -$659.0K | -$557.0K | -$146.0K | -$4.2M | |||||
| Adjustments For Sharebased Payments | $901.0K | $1.5M | $1.2M | $4.9M | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $927.0K | $509.0K | $604.0K | $928.0K | $598.0K | $464.0K | $383.0K | $472.0K | $516.0K | $110.0K | $696.0K | $964.0K | $628.0K | $538.0K | $327.0K |
| Other Nonrecurring Income | $0.00 | $0.00 | $0.00 | $12.0K | $14.0K | $13.0K | $6.0K | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | |||
| Depreciation | $8.0K | $13.0K | $14.0K | $16.0K | $9.0K | ||||||||||
| Stock Issued During Period Value Issued For Services | $70.0K | $6.0M | $601.0K | $5.0K | $2.5M | $9.5M | $9.9M | ||||||||
| Finance Expenses Net | -$4.0K | -$9.0K | -$3.0K | -$39.0K | -$19.0K | ||||||||||
| Stock Issued During Period Value Stock Options Exercised | $7.1M | $555.0K | $13.0K | $13.0K | $122.0K | $48.0K | $227.0K | ||||||||
| Exercise Of Warrants Value | $180.0K | $150.0K | $13.0K | $60.0K | $30.0K | $3.1M | $24.0K | ||||||||
| Interest Received | $0.00 | $39.0K | $0.00 | ||||||||||||
| Financial Expenses Income Net | |||||||||||||||
| Adjustments For Sharebased Payments |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.